Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide vs Metformin in Obese Women with PCOS
NCT05646199Phase 3Not yet recruiting
- Sponsor
- University of Hull
- Start
- Mar 2025
- Primary completion
- Sep 2025
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of semaglutide in polycystic ovary syndrome (PCOS), sponsored by University of Hull. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05646199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05646199.